Alan P. Venook
0000-0001-9749-6548
Publication & Citation Trends
Most Cited Works
2,267
Publications
776 total
Ending the Controversy Around Pretreatment Dihydropyrimidine Dehydrogenase (DPD/DPYD) Testing Heightens the Controversy Over Appropriate Fluoropyrimidine Dosing.
Cited by 1
Semantic Scholar
Indian Hedgehog expression and association with cetuximab benefit in metastatic colorectal cancer (mCRC): Evidence from CALGB (Alliance)/SWOG 80405.
Cited by 0
Semantic Scholar
Abstract 6751: Differences in survival outcomes among metastatic colorectal cancer patients across fibroblast growth factor receptor 2 and 3 expression levels
Cited by 0
Semantic Scholar
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction.
Cited by 0
Semantic Scholar
Efficacy of combination therapy with anti-EGFR antibody as first-line treatment for RAS wild-type metastatic colorectal cancer according to anatomical tumor location from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Cited by 0
Semantic Scholar
Neuroligin family genes expression associated with first-line treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC): Data from CALGB/SWOG 80405 (Alliance).
Cited by 0
Semantic Scholar
Abstract 1011: Correlation of mitophagy related genes expression and clinical outcome in metastatic colorectal cancer patients enrolled in CALGB (Alliance)/SWOG 80405
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(304)
Hepatocellular Carcinoma Treatment and Prognosis
(148)
Cancer Genomics and Diagnostics
(114)
Gastric Cancer Management and Outcomes
(94)
Genetic factors in colorectal cancer
(87)
Frequent Co-Authors
Affiliations
Northwestern University
University of North Carolina at Chapel Hill
University of Southern California
University of Maryland, Baltimore
Brigham and Women's Hospital